Patients on tirzepatide were twice as likely to lose at least 25% of their body weight, and nearly one in five (19.7%) lost 30% or more, compared to fewer than one in fourteen (6.9%) on semaglutide.[1] Both medications also improved blood pressure, blood sugar, and cholesterol levels, with greater improvements seen in the tirzepatide group, which tracked with the larger weight reduction.[1] The safety profiles were similar
However, it is important to inform your doctor if you notice any persistent or worsening GI disturbances such as severe abdominal pain, nausea, vomiting, diarrhea, and unexpected weight loss
NICE guidance does not reference berberine in any clinical pathway for diabetes (NG28), cardiovascular disease (NG238), obesity, or metabolic syndrome
The results show that, L
Using a low-purity or improperly synthesized peptide is like trying to build a precision machine with faulty parts